New uses for old drugs: neonatal diabetes and sulphonylureas
- PMID: 20197050
- DOI: 10.1016/j.cmet.2010.02.004
New uses for old drugs: neonatal diabetes and sulphonylureas
Abstract
The discovery that their neonatal diabetes is caused by gain-of-function mutations in the K(ATP) channel has enabled many patients to switch from insulin to oral sulphonylurea drugs. Here, I review molecular, physiological, and clinical features of this change in therapy.
2010 Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
